Chlordiazepoxide is a competitive thyrotropin-releasing hormone receptor antagonist in GH3 pituitary tumour cells
- 1 February 1985
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 127 (1) , 63-70
- https://doi.org/10.1016/s0006-291x(85)80126-1
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Thyrotropin-releasing hormone increases cytosolic free Ca2+ in clonal pituitary cells (GH3 cells): direct evidence for the mobilization of cellular calcium.The Journal of cell biology, 1984
- Ligands for benzodiazepine receptors with positive and negative efficacyBiochemical Pharmacology, 1984
- Chlordiazepoxide displaces thyrotropin-releasing hormone (TRH) bindingEuropean Journal of Pharmacology, 1984
- Benzodiazepines compete for thyrotropin-releasing hormone receptor binding: Micromolar potency in rat pituitary, retina and amygdalaNeuroscience Letters, 1983
- Phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate: Lipids in search of a functionCell Calcium, 1982
- Somatostatin antagonist analog increases GH, insulin, and glucagon release in the ratPeptides, 1982
- Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.The Journal of cell biology, 1982
- Micromolar Affinity Benzodiazepine Receptors: Identification and Characterization in Central Nervous SystemScience, 1982
- Chemical design of antagonists of substance PActa Physiologica Scandinavica, 1981
- Benzodiazepine receptors in rat brainNature, 1977